Fig. 3From: Integrating expert opinion with clinical trial data to extrapolate long-term survival: a case study of CAR-T therapy for children and young adults with relapsed or refractory acute lymphoblastic leukemiaModeled survival based on ELIANA trial data (1.5 years) without expert information. Solid lines represent point estimates and dashed lines the 95% credible intervalsBack to article page